Multiple cancer cell types release LIF and Gal3 to hijack neural signals

Abstract

Neural signals can significantly influence cancer prognosis. However, how cancer cells may proactively modulate the nervous system to benefit their own survival is incompletely understood. In this study, we report an overlapping pattern of brain responses, including that in the paraventricular nucleus of the hypothalamus, in multiple mouse models of peripheral cancers. A multi-omic screening then identifies leukemia inhibitory factor (LIF) and galectin-3 (Gal3) as the key cytokines released by these cancer cell types to trigger brain activation. Importantly, increased plasma levels of these two cytokines are observed in patients with different cancers. We further demonstrate that pharmacologic or genetic blockage of cancer cell-derived LIF or Gal3 signaling abolishes the brain responses and strongly inhibits tumor growth. In addition, ablation of peripheral sympathetic actions can similarly restore antitumor immunity. These results have elucidated a novel, shared mechanism of multiple cancer cell types hijacking the nervous system to promote tumor progression.

Peripheral cancer remodeling of central neural system

“…6 However, CNS circuit remodeling mediated by peripheral cancer without evidence of brain metastasis has many unanswered questions. Xu et al 7 innovatively apply a top-down approach, using multi-omics across four peripheral cancers to identify secretory factors convergent on a similar neuronal pattern within the CNS (Fig. 1).…”